Soffia Gudbjörnsdottir

Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, Sweden

AstraZeneca (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Boehringer Ingelheim (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, lecture fees and research grants)Eli Lilly (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Merck Sharp & Dohme (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Novo Nordisk (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Sanofi (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)

Presentation(s):

• Association of Glucagon-like peptide-1 Receptor Agonists with Serious Liver Events: Scandinavian Cohort Study

  Friday, August 26, 2022
  2:45 PM – 3:00 PM CEST

• Sodium-glucose Co-transporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study

  Sunday, August 28, 2022
  8:30 AM – 8:45 AM CEST